Table 4 Surgical treatment outcomes (n = 41 for each group).

From: Evaluating the efficacy of neoadjuvant immunotherapy combined with chemotherapy for stage IIIa non-small cell lung cancer

Title

Name

Control group (n)

Experimental group (n)

X2/t

P

R0 Excision

No

17 (41.46%)

7 (17.07%)

5.891

0.015

Yes

24 (58.54%)

34 (82.93%)

Operation time (min)

137.83 ± 29.38

144.93 ± 32.88

− 1.031

0.306

Intraoperative bleeding volume (mL)

227.66 ± 42.29

216.22 ± 33.85

1.352

0.180

Total number of lymph node dissection

22.85 ± 6.91

21.12 ± 8.66

1.001

0.320

Number of metastatic lymph nodes

4.80 ± 1.68

3.27 ± 1.58

4.269

< 0.01

Lymph node metastasis rate

0.23 ± 0.12

0.17 ± 0.08

2.702

0.008

Complication

None

22 (53.66%)

33 (80.49%)

6.681

0.010

Yes

19 (46.34%)

8 (19.51%)